EX-99.1 2 exhibit99.htm 2009 VOTING RESULTS

exhibit99.htm

ONCOLYTICS BIOTECH INC.

Annual and Special Meeting of Holders of

Common Shares of

Oncolytics Biotech Inc. (the "Issuer")

May 5, 2009

REPORT OF VOTING RESULTS

National Instrument 51-102 – Continuous Disclosure Obligations

Section 11.3

General Business				Outcome of Vote
1.	The election of the following nominees as directors of the Issuer for the ensuing year or until their successors are elected or appointed			Carried
	(a)	Bradley G. Thompson
	(b)	Douglas Ball
	(c)	Ger Van Amersfoort
	(d)	William A. Cochrane
	(e)	Jim Dinning
	(f)	Ed Levy
	(g)	J. Mark Lievonen
	(h)	Robert B. Schultz
	(i)	Fred A. Stewart
2.	The appointment of Ernst & Young LLP, Chartered Accountants, as auditors of the Issuer to hold office until the next annual meeting			Carried
				Votes by Ballot
Special Business			Outcome of Vote	Votes For	Votes Against
1.	The approval of an increase in the number of common shares reserved for issuance pursuant to the stock option plan of the Issuer		Carried	5,138,791	1,894,213